Clinical Trials in Phoenix

Showing 8241-8260 of 16,646 trials

Study of Intravenous Erenumab in Patients With Status Migrainosus

NCT04920331

The investigators will evaluate the efficacy for use of intravenous erenumab 140mg for treatment of status migrainosus in an open-label, pilot study.

Status Migrainosus

Mayo ClinicStarted Sep 2021

Phoenix, Arizona, United States

COMPLETEDNA11 miles

Hair Loss Prevention Study for Pancreatic Cancer

NCT04492800

Pilot study intended for hair loss prevention in patients with pancreatic cancer who are receiving treatment containing nab-paclitaxel, gemcitabine and cisplatin.

Alopecia

HonorHealth Research Institute9 participantsStarted Dec 2019

Scottsdale, Arizona, United States

COMPLETEDPhase 317 miles

A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension

NCT02636946

This study will evaluate the intraocular pressure (IOP)-lowering effect and safety of Bimatoprost SR compared with selective laser trabeculoplasty in participants with open-angle glaucoma or ocular hypertension who are not adequately managed with topical IOP-lowering medication for reasons other than medication efficacy (e.g., due to intolerance or nonadherence).

GlaucomaOpen-Angle Ocular Hypertension

Allergan144 participantsStarted Feb 2016

Dothan, Alabama, United States • Chandler, Arizona, United States • Chandler, Arizona, United States +30 more locations

Study of Intravenous Erenumab in Patients With Status Migrainosus

Hair Loss Prevention Study for Pancreatic Cancer

A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension

Find Trials by Condition in Phoenix

Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID

Retrospective Evaluation of 5-FU Exposure Optimization in CRC Patients

PEN-866 in Patients With Advanced Solid Malignancies

Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis

Herniorrhaphy Study for Opioid Elimination

Expanded Access Remdesivir (RDV; GS-5734™)

NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung Cancer

Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer

COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80

RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma

Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)

A Study Evaluating the Safety and Pharmacokinetics of Atezolizumab Administered in Combination With Hu5F9-G4 to Patients With Relapsed and/or Refractory Acute Myeloid Leukemia

A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPD

Comparison of Visual Acuity Performed in Office Versus In Residence